Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Brad Poore
Affiliation
ORCID
Career Start Year
2014
Papers
13
H Index
9
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36849558
A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasis.
Nat Cell Biol
2023
35267619
Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine Pathways.
Cancers (Basel)
2022
33571541
TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma.
Cancer Lett
2021
34118242
A comparison of SARS-CoV-2 nucleocapsid and spike antibody detection using three commercially available automated immunoassays.
Clinical Biochemistry
2021
31819973
PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of BRAF V600E Mutational Status.
J Neuropathol Exp Neurol
2020
32164294
Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma.
Cancers (Basel)
2020
31300448
Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine.
Clin Cancer Res
2019
30239952
Inhibition of mTORC1 in pediatric low-grade glioma depletes glutathione and therapeutically synergizes with carboplatin.
Neuro Oncol
2019
27559084
Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer.
Proc Natl Acad Sci U S A
2016
27200176
Allosteric Glutaminase Inhibitors Based on a 1,4-Di(5-amino-1,3,4-thiadiazol-2-yl)butane Scaffold.
ACS Med Chem Lett
2016
26454069
Dysregulated metabolism contributes to oncogenesis.
Semin Cancer Biol
2015
26590477
Designing a broad-spectrum integrative approach for cancer prevention and treatment.
Semin Cancer Biol
2015
25413013
Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources.
Nature Communications
2014
1 - 13 of 13
Column Actions
Search
Recommended Authors
Collaborators
Charles G Eberhart
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers
6
Eric H Raabe
Co-authored papers
6
Lee W Jones
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Jeffrey A Rubens
Co-authored papers
2
Ian F Pollack
University of Pittsburgh School of Medicine
Co-authored papers
2
Gregory A Michelotti
Inc. Research Triangle Park
Co-authored papers
2
Jason W Locasale
Duke University
Co-authored papers
2
Alberto Broniscer
Co-authored papers
2
Matthew D Hirschey
Duke Molecular Physiology Institute, Duke University School of Medicine
Co-authored papers
2
Baoli Hu
Co-authored papers
2
Han Zou
Co-authored papers
2
Costas A Lyssiotis
Co-authored papers
2
Apeng Chen
Co-authored papers
1
Jill P Mesirov
University of California San Diego
Co-authored papers
1
Fei Liu
Co-authored papers
1
Guifa Xi
Co-authored papers
1
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Co-authored papers
1
Thomas E Carey
Kresge Hearing Research Institute, University of Michigan ann arbor
Co-authored papers
1
Yongchang Guan
Co-authored papers
1
Bin Xie
Co-authored papers
1
Liang Zhao
Co-authored papers
1
Karl Herrup
Co-authored papers
1
Thomas Hartung
University of Konstanz
Co-authored papers
1
George K Gittes
Co-authored papers
1
Olivier Saulnier
Co-authored papers
1
Robert M Friedlander
Co-authored papers
1
Sameer Agnihotri
Co-authored papers
1
Robert B Robey
Geisel School of Medicine at Dartmouth and US Department of Veterans Affairs
Co-authored papers
1
Gary Kohanbash
Co-authored papers
1
Sarah J Hainer
Co-authored papers
1
1 - 30